"From research to care, our customers need solutions that bring the best of clinical and scientific rigor together with AI to deliver the next generation of healthcare - one that is as precise as it is personal. This statement from Chairman and CEO Stephen Gillett encapsulates Verily's strategic direction, emphasizing the integration of artificial intelligence with established healthcare practices to create personalized, precise medical solutions."
"Verily announced that with its $300 million investment round, it will change from an LLC to a corporation and rename itself Verily Health Inc. As a result, Alphabet now has a minority stake rather than a controlling one in the business. This restructuring marks a significant shift in corporate governance and independence for the life sciences division."
Verily, Alphabet's life sciences subsidiary formerly known as Google Life Sciences, is undergoing significant restructuring. The company secured $300 million in investment funding and transitioned from an LLC to a corporation, rebranding as Verily Health Inc. This restructuring reduces Alphabet's ownership from controlling to minority stake. The company is prioritizing AI integration across its healthcare operations, emphasizing solutions combining clinical rigor with artificial intelligence for personalized medicine. Verily's strategic direction reflects broader tech industry trends toward AI adoption. The company closed its medical device division in 2025, signaling a deliberate pivot toward AI-focused healthcare innovation rather than traditional device manufacturing.
Read at Engadget
Unable to calculate read time
Collection
[
|
...
]